CUSIP: 58436Q203
Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,885,294
-
Share change
-
-316,839
-
Total reported value
-
$9,766,573
-
Price per share
-
$5.19
-
Number of holders
-
24
-
Value change
-
-$1,658,515
-
Number of buys
-
8
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP 58436Q203?
CUSIP 58436Q203 identifies MDGN - MEDGENICS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2014
-
Previous quarter:
Q2 2014
Recent filing periods for CUSIP 58436Q203:
Institutional Holders of MEDGENICS INC - COM NEW (MDGN) as of Q3 2014
As of 30 Sep 2014,
MEDGENICS INC - COM NEW (MDGN) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,885,294 shares.
The largest 10 holders included
VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BlackRock Institutional Trust Company, N.A., Legal & General Group Plc, Belmont Global Advisors, Inc., BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, PERCEPTIVE ADVISORS LLC, LPL Financial LLC, and BlackRock Fund Advisors.
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.